KM, W., CR, M., B, Q., AK, W., MS, L., CW, M., . . . BC, V. (2022). Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis. PLoS pathogens, 18(2), e1009862. https://doi.org/10.1371/journal.ppat.1009862
Chicago Style (17th ed.) CitationKM, Wilburn, et al. "Pharmacological and Genetic Activation of CAMP Synthesis Disrupts Cholesterol Utilization in Mycobacterium Tuberculosis." PLoS Pathogens 18, no. 2 (2022): e1009862. https://doi.org/10.1371/journal.ppat.1009862.
MLA (9th ed.) CitationKM, Wilburn, et al. "Pharmacological and Genetic Activation of CAMP Synthesis Disrupts Cholesterol Utilization in Mycobacterium Tuberculosis." PLoS Pathogens, vol. 18, no. 2, 2022, p. e1009862, https://doi.org/10.1371/journal.ppat.1009862.